ID

14798

Description

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT00754325

Link

https://clinicaltrials.gov/show/NCT00754325

Keywords

  1. 4/28/16 4/28/16 -
Uploaded on

April 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Advanced Breast Cancer NCT00754325

Eligibility Advanced Breast Cancer NCT00754325

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed hormone receptor positive (hr+) [(estrogen receptor (er+) and/or progesterone receptors(pgr+)] breast cancer according to immunohistochemistry (ihc)
Description

hormone receptor positive breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C1562029
measureable or evaluable-only disease
Description

measureable disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
human epidermal growth factor receptor 2+ (her2+) or her2- breast cancer
Description

epidermal growth factor receptor breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C1960925
males and females ≥18 years of age
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
females are post menopausal or surgically sterile
Description

post menopausal or surgically sterile

Data type

boolean

Alias
UMLS CUI [1]
C0021359
UMLS CUI [2]
C0232970
recurrent or progressive advanced breast cancer (locally-advanced or metastatic), that has progressed: (a) during or within 12 months after completion of adjuvant aromatase inhibitor (ai) treatment or (b) during ai treatment in advanced setting (metastatic therapy)
Description

recurrent or progressive advanced breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C0596224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast feeding
Description

pregnant or breast feeding

Data type

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0006147
>1 chemotherapy regimen for advanced disease
Description

chemotherapy regimen

Data type

boolean

Alias
UMLS CUI [1]
C0392920
pleural or pericardial effusion
Description

pleural or pericardial effusion

Data type

boolean

Alias
UMLS CUI [1]
C0032227
UMLS CUI [2]
C0031039
serious cardiac condition
Description

cardiac condition

Data type

boolean

Alias
UMLS CUI [1]
C0018799

Similar models

Eligibility Advanced Breast Cancer NCT00754325

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
hormone receptor positive breast cancer
Item
histologically confirmed hormone receptor positive (hr+) [(estrogen receptor (er+) and/or progesterone receptors(pgr+)] breast cancer according to immunohistochemistry (ihc)
boolean
C1562029 (UMLS CUI [1])
measureable disease
Item
measureable or evaluable-only disease
boolean
C1513041 (UMLS CUI [1])
epidermal growth factor receptor breast cancer
Item
human epidermal growth factor receptor 2+ (her2+) or her2- breast cancer
boolean
C1960925 (UMLS CUI [1])
age
Item
males and females ≥18 years of age
boolean
C0001779 (UMLS CUI [1])
post menopausal or surgically sterile
Item
females are post menopausal or surgically sterile
boolean
C0021359 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
recurrent or progressive advanced breast cancer
Item
recurrent or progressive advanced breast cancer (locally-advanced or metastatic), that has progressed: (a) during or within 12 months after completion of adjuvant aromatase inhibitor (ai) treatment or (b) during ai treatment in advanced setting (metastatic therapy)
boolean
C0596224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnant or breast feeding
Item
pregnant or breast feeding
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
chemotherapy regimen
Item
>1 chemotherapy regimen for advanced disease
boolean
C0392920 (UMLS CUI [1])
pleural or pericardial effusion
Item
pleural or pericardial effusion
boolean
C0032227 (UMLS CUI [1])
C0031039 (UMLS CUI [2])
cardiac condition
Item
serious cardiac condition
boolean
C0018799 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial